Latest Commercialisation News

Sunshine Metals has completed resource infill drilling at its Plateau gold-silver prospect and reconnaissance drilling at the Salla gold-copper-zinc prospect, delivering results that support an upcoming resource update and further exploration.

Nanoveu Limited has raised A$2 million through a strategic placement to accelerate the commercialisation of its 16nm ECS-DoT chip and expand its EMASS modular AIoT platform, positioning the company for global growth.

Buru Energy has agreed to sell its hydrogen-focused subsidiary 2H Resources and non-core Canning Basin assets to Koloma Australia for up to AUD 2 million, marking a strategic pivot towards its Rafael Gas Project.

Echo IQ has secured a pivotal reseller agreement with US-based SARC MedIQ, unlocking access to over 300 healthcare facilities and accelerating adoption of its AI-driven EchoSolv AS technology across the American cardiology landscape.

Orthocell has achieved a significant milestone by recording its first US sales revenue for Remplir™, its flagship nerve repair product, shortly after FDA clearance and initial surgical use.

Emperor Energy has raised $3.7 million through a share placement to advance the Judith-2 appraisal well in Victoria’s Gippsland Basin, backed by independent resource validation and strategic infrastructure proximity.

Telix Pharmaceuticals has achieved a key milestone with its next-generation prostate cancer imaging agent, Gozellix, receiving a permanent HCPCS code from U.S. Medicare. This paves the way for broader reimbursement and market adoption starting October 2025.

Anatara Lifesciences has strengthened its intellectual property portfolio with a Japanese patent for its GaRP gastrointestinal health product, while progressing pre-clinical studies in its Anti-Obesity Project. The company also confirmed registration of its R&D Tax Incentive application for 2024-2025.

Sparc Technologies progresses its pioneering green hydrogen pilot plant and graphene-based coatings, backed by a significant government grant and a successful capital raise.

Orthocell Limited has reported a record FY2025 revenue of A$9.19 million, driven by strong sales of its nerve repair product Remplir™ in Australia and a promising US market launch following FDA clearance.

The Environmental Group Limited (ASX – EGL) has landed a $1.9 million contract to design and build its inaugural PFAS treatment plant, marking a key milestone in commercialising its proprietary environmental technology.

HyTerra Limited is advancing its Nemaha Project with the imminent spudding of the McCoy 1 well, moving towards data-driven exploration backed by strategic funding from Fortescue Future Industries Technologies.